Resultados de procura - Baselga, Josè

Pharmacology in the Era of Targeted Therapies: The Case of PI3K Inhibitors por Toska, Eneda, Baselga, José

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Targeted therapies for breast cancer por Higgins, Michaela J., Baselga, José

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Molecular Pathways: AXL, a Membrane Receptor Mediator of Resistance to Therapy por Scaltriti, Maurizio, Elkabets, Moshe, Baselga, José

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Deconstructing feedback-signaling networks to improve anticancer therapy with mTORC1 inhibitors por Carracedo, Arkaitz, Baselga, Jose, Pandolfi, Pier Paolo

Ligazón do recurso Ligazón do recurso

Treatment of HER2-Positive Metastatic Breast Cancer por Swain, Sandra M., Clark, Emma, Baselga, José

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Implementing Genome-Driven Oncology por Hyman, David M., Taylor, Barry S., Baselga, José

Ligazón do recurso Ligazón do recurso Ligazón do recurso

A view on drug resistance in cancer por Vasan, Neil, Baselga, José, Hyman, David M.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism por Fuentes, Gloria, Scaltriti, Maurizio, Baselga, José, Verma, Chandra S

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Advances in the management of HER2-positive early breast cancer por Baselga, José, Coleman, Robert E., Cortés, Javier, Janni, Wolfgang

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Pancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programs por Osmanbeyoglu, Hatice U., Toska, Eneda, Chan, Carmen, Baselga, José, Leslie, Christina S.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Unconventional Secretion is a Major Contributor of Cancer Cell Line Secretomes por Villarreal, Laura, Méndez, Olga, Salvans, Cándida, Gregori, Josep, Baselga, José, Villanueva, Josep

Ligazón do recurso Ligazón do recurso Ligazón do recurso

The Carboxy-terminal Cysteine of the Tetraspanin L6 Antigen Is Required for Its Interaction with SITAC, a Novel PDZ Protein por Borrell-Pagès, Maria, Fernández-Larrea, Juan, Borroto, Aldo, Rojo, Federico, Baselga, José, Arribas, Joaquín

Ligazón do recurso Ligazón do recurso

Proteomic Identification of Desmoglein 2 and Activated Leukocyte Cell Adhesion Molecule as Substrates of ADAM17 and ADAM10 by Difference Gel Electrophoresis por Bech-Serra, Joan J., Santiago-Josefat, Belén, Esselens, Cary, Saftig, Paul, Baselga, José, Arribas, Joaquín, Canals, Francesc

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Biosynthesis of tumorigenic HER2 C-terminal fragments by alternative initiation of translation por Anido, Judit, Scaltriti, Maurizio, Bech Serra, Joan Josep, Josefat, Belén Santiago, Rojo Todo, Federico, Baselga, José, Arribas, Joaquín

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance por Wehrenberg-Klee, Eric, Turker, N. Selcan, Heidari, Pedram, Larimer, Benjamin, Juric, Dejan, Baselga, José, Scaltriti, Maurizio, Mahmood, Umar

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-cont... por Miles, David, Baselga, José, Amadori, Dino, Sunpaweravong, Patrapim, Semiglazov, Vladimir, Knott, Adam, Clark, Emma, Ross, Graham, Swain, Sandra M.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial por Bonner, James, Giralt, Jordi, Harari, Paul, Spencer, Sharon, Schulten, Jeltje, Hossain, Anwar, Chang, Shao-Chun, Chin, Steve, Baselga, José

Ligazón do recurso Ligazón do recurso Ligazón do recurso

TARGETING THE MUC1-C ONCOPROTEIN DOWNREGULATES HER2 ACTIVATION AND ABROGATES TRASTUZUMAB RESISTANCE IN BREAST CANCER CELLS por Raina, Deepak, Uchida, Yasumitsu, Kharbanda, Akriti, Rajabi, Hasan, Panchamoorthy, Govind, Jin, Caining, Kharbanda, Surender, Scaltriti, Maurizio, Baselga, Jose, Kufe, Donald

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Molecular Features and Survival Outcomes of the Intrinsic Subtypes Within HER2-Positive Breast Cancer por Prat, Aleix, Carey, Lisa A., Adamo, Barbara, Vidal, Maria, Tabernero, Josep, Cortés, Javier, Parker, Joel S., Perou, Charles M., Baselga, José

Ligazón do recurso Ligazón do recurso Ligazón do recurso

An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors por Jonas, Oliver, Landry, Heather M., Fuller, Jason E., Santini, John T., Baselga, Jose, Tepper, Robert I., Cima, Michael J., Langer, Robert

Ligazón do recurso Ligazón do recurso Ligazón do recurso